Top compounds associated with response to RP11-327P2.7


Feature Type Standardized
Nominal ANOVA
mRNA austocystin d CTRPv2 pan-cancer AAC 0.055 0.1
mRNA Bortezomib gCSI pan-cancer AAC -0.093 0.1
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.052 0.1
mRNA Gemcitabine gCSI pan-cancer AAC -0.085 0.1
mRNA Repligen 136 CTRPv2 pan-cancer AAC 0.054 0.1
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.05 0.2
mRNA tigecycline CTRPv2 pan-cancer AAC -0.071 0.2
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.078 0.2
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.05 0.2
mRNA necrosulfonamide CTRPv2 pan-cancer AAC 0.055 0.2
Download CSV